Major european study tests if Kidney-Saving surgery is safe for rare cancer

NCT ID NCT07077447

Recruiting now Knowledge-focused Sponsor: Zealand University Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study follows 2500 people with a rare cancer of the kidney's upper urinary tract (UTUC) to see if kidney-sparing surgery works as well as removing the whole kidney. Researchers will track survival, cancer return, kidney function, and quality of life over 10 years. Anyone diagnosed with UTUC can join, and the goal is to improve treatment guidelines.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for UPPER URINARY TRACT UROTHELIAL CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Colorectal Neoplasms, Hereditary Nonpolyposis renal pelvis/ureter urothelial carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

UPPER URINARY TRACT UROTHELIAL CARCINOMA

Contacts and locations

Locations

Department of Urology Aarhus University Hospital
NOT_YET_RECRUITING

Aarhus N, 8200, Denmark
Department of Urology, Copenhagen University Hospital - Rigshospitalet
NOT_YET_RECRUITING

København Ø, 2100, Denmark
Department of Urology, Zealand University Hospital
RECRUITING

Roskilde, 4000, Denmark
Haukeland University Hospital
NOT_YET_RECRUITING

Bergen, 5009, Norway
Herlev Gentofte Hospital
NOT_YET_RECRUITING

Herlev, 2730, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.